Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Open Forum Infectious Diseases|February 23, 2023
Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care HospitalsJoachim Doua, Jeroen Geurtsen, Jesus Rodriguez-Baño, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational studyJoachim Doua, Miquel Ekkelenkamp, Theo Verheij, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 17, 2022
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in JapanTetsuya Matsumoto, Hiroshige Mikamo, Hiroki Ohge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance StudiesEveline Weerdenburg, Todd Davies, Brian Morrow, et al.
Expert Review of Anti-Infective Therapy|October 6, 2025
Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysisBaher Elezbawy, Nada Abaza, Mirna Fasseeh, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2024
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli diseaseEnya Arconada Nuin, Tuba Vilken, Basil Britto Xavier, et al.
Vaccine|November 28, 2018
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitroAnne Marie Queenan, David J Dowling, Wing Ki Cheng, et al.
Clinical and Vaccine Immunology : CVI|October 27, 2006
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescentsDominique Boutriau, Jan Poolman, Ray Borrow, et al.
Infection|January 24, 2024
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational studyJoachim Doua, Jesús Rodríguez-Baño, Rachel Froget, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
Pageof 6